157 related articles for article (PubMed ID: 3923649)
1. Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
Juhan-Vague I; Chignard M; Poisson C; Roul C; Billerey M; Buonocore M; Driss F; Vague P; Benveniste J
Thromb Res; 1985 Apr; 38(1):83-9. PubMed ID: 3923649
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
5. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
6. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
7. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
8. Reduced sensitivity of human platelets to PAF-acether following ticlopidine intake.
Chignard M; Lalau Keraly C; Delautier D; Sebag C; Bouloux C; Motte G; Benveniste J
Haemostasis; 1989; 19(4):213-8. PubMed ID: 2509309
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of three new synthetic compounds on human platelet aggregation.
Chignard M; Maamer M; Lalau Keraly C; Greiss M; Aurousseau M; Benveniste J
Thromb Res; 1986 Nov; 44(4):445-54. PubMed ID: 3099419
[TBL] [Abstract][Full Text] [Related]
10. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
11. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
12. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
13. Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used.
Ahmed Y; Sullivan MH; Elder MG
Thromb Haemost; 1991 May; 65(5):474-7. PubMed ID: 1908139
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Chignard M; Wal F; Lefort J; Vargaftig BB
Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
[TBL] [Abstract][Full Text] [Related]
15. Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.
Khan SN; Lane PA; Smith AD
Eur J Pharmacol; 1985 Jan; 107(2):189-98. PubMed ID: 3920056
[TBL] [Abstract][Full Text] [Related]
16. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Altman R; Scazziota A
Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
[TBL] [Abstract][Full Text] [Related]
17. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
Altman R; Scazziota A; Rouvier J; Cacchione R
Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
[TBL] [Abstract][Full Text] [Related]
18. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
Chignard M; Le Couedic JP; Coëffier E; Benveniste J
Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
[TBL] [Abstract][Full Text] [Related]
19. Role of paf-acether and related ether-lipid metabolism in platelets.
Chignard M; Coëffier E; Benveniste J
Adv Exp Med Biol; 1985; 192():309-26. PubMed ID: 2422886
[No Abstract] [Full Text] [Related]
20. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C
J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
